In an important early study by Miller et al., 19 AML patients received haploidentical NK cell infusions at doses up to 2 × 107 cells/kg with or without modified IL-2 injections, with five patients achieving a morphologic CR [61]. This evidence concerns the gene IL2 and acute myeloid leukemia.